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In addition to imaging the lymphatics and detecting various types of lymphatic leakage, lymphangiography is a 
therapeutic option for patients with chylothorax, chylous ascites, and lymphatic fistula. Percutaneous thoracic duct 
embolization, transabdominal catheterization of the cisterna chyli or thoracic duct, and subsequent embolization of the 
thoracic duct is an alternative to surgical ligation of the thoracic duct. In this pictorial review, we present the detailed 
technique, clinical applications, and complications of lymphangiography and thoracic duct embolization.
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INTRODUCTION
Lymphatic leakage is a rare but severe complication 
that can occur after various surgical procedures, 
such as pancreaticoduodenectomy, abdominothoracic 
esophagectomy, inguinal lymph node resection, and 
nephrouretectomy (1). It can also occur from non-surgical 
pathologies including lymphangioleiomyomatosis and 
post-radiation treatment. Lymphatic leaks can occur 
anywhere along the pathway of lymph that begins in all 
four extremities. The clinically more important pathway 
starts from the intestinal lymphatic ducts and continues 
through the cisterna chyli and into the thoracic duct (Fig. 
1). Lymphatic leakage can induce local complications, such 
as infections or delayed wound healing, or cause severe 
malnutrition in patients with chylothorax or chylous ascites 
(1). 
Lymphangiography (LG) is a valuable tool for the 
detection of various types of lymphatic leakage including 
chylothorax, chylous ascites, and lymphatic fistulae (2-9). 
Previous studies have described a leakage detection rate of 
64–78% (3, 4, 7).
Besides the diagnostic role of identifying the lymphatic 
leaks, recently published reports indicate LG plays a 
therapeutic role for lymphatic leakage (1, 3-7). The 
mechanism by which LG reduces lymphatic leaks has not yet 
been fully clarified, although some authors have suggested 
that Lipiodol, an ethiodized oil contrast agent, undergoes 
an inflammatory and granulomatous reaction during 
its extravasation (3, 10). The therapeutic effect is also 
attributed to the embolic properties of Lipiodol, as Lipiodol 
infused during LG accumulates at the point of leakage 
outside as well as within the lymphatics (3).
For the treatment of chylothorax, percutaneous thoracic 
duct embolization (TDE) is an established alternative to 
surgical ligation of the thoracic duct (11-13). TDE is a 
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minimally invasive procedure in which opacification of 
the lymphatic system by LG is followed by transabdominal 
catheterization of the cisterna chyli or thoracic duct and 
subsequent occlusion of the thoracic duct with embolization 
to prevent further leak. 
The purpose of this pictorial essay is to acquaint 
radiologists and interventional radiologists to the details 
of technique and clinical applications of LG and TDE in the 
diagnosis and treatment of postoperative lymphatic leakage. 
Technique
There are two methods of LG: pedal LG and intranodal 
LG. Conventional pedal LG, which involves the isolation 
and cannulation of pedal lymphatic vessels and injection 
of Lipiodol, is time-consuming and requires an incision to 
expose the pedal lymphatics (3-7).
Intranodal LG was developed to evaluate the tumoral 
involvement of inguinal, pelvic, and lumbar lymph nodes 
(14). The technique relies on ultrasound-guidance to access 
inguinal lymph nodes for direct lymph node access and 
injection of Lipiodol. Accessing the inguinal lymph nodes 
requires no incisions and bypasses the lower extremities, 
thus decreasing the procedure time for LG and TDE, 
radiation dose, and volume of the contrast medium (8, 9, 
15). This technique seems appealing in children in view 
of the small size of the lymphatic channels and commonly 
enlarged inguinal lymph nodes (9).
Pedal LG
In patients with abdominal or thoracic lymphatic leakage, 
either the right or left foot is used for pedal LG. However, 
in patients with inguinal or pelvic lymphatic leakage, the 
ipsilateral foot to the site of the leakage is used (1). Five 
to 10 mL of indigo carmine (Korea United Pharm., Seoul, 
Korea) is injected into the cutaneous and subcutaneous web 
spaces of the first to third toe spaces after administering 
lidocaine as a local anesthetic. After waiting 20–30 
minutes, the course of the lymphatic vessels is identified 
at the dorsum of the foot. A longitudinal or transverse 
cutaneous incision at the base of the first metatarsal bone 
is made to expose a lymphatic vessel with blue staining 
after dissection of the surrounding tissue. The isolated 
lymphatic vessel is then cannulated using a 30-G LG needle 
(Cook, Bloomington, IN, USA) (Fig. 2). Often, a surgical 
loop or magnifying loop is utilized to better visualize the 
lymphatics. The needle and the lymphatic vessel are firmly 
tied together using 3-0 silk thread and then secured with 
adhesive strips (Fig. 2).
After accessing the lymphatic vessel, 6–12 mL of Lipiodol 
(Guerbet, Paris, France) are injected at the rate of 0.2–0.4 
mL/minute using the dedicated Cordis lymphangiogram 
pump (Johnson and Johnson, Miami Lakes, FL, USA) or, 
more commonly, an advanced anesthesia injection pump. 
Serial fluoroscopic spot images are obtained upwardly every 
5–10 minutes over the course of the injected Lipiodol. If 
Lipiodol does not reach the area of interest, normal saline 
at the same rate can be injected to push Lipiodol further 
into the area of interest. The needles are then removed and 
the wounds are sutured after the injection is completed.
Pedal LG is considered to be technically successful if the 
lymphatic vessel is successfully selected and the lymphatic 
channels of interest including cisterna chyli are adequately 
visualized using Lipiodol. 
Intranodal LG
The largest and most distal (away from the inguinal area) 
Fig. 1. Schematic drawing of chyle pathway. Lumbar lymphatics 
drain not only lumbar region but also lower extremities. Lumbar, 
intestinal, and liver lymphatics join and form cisterna chyli (CC) which 
finally empties into left subclavian vein. 
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inguinal lymph node is directly accessed under ultrasound 
guidance using a 25-gauge spinal needle (Tae-Chang 
Industrial, Gongju, Korea) (Fig. 3). To minimize needle 
movement, the needle is assembled prior to nodal access. 
The stylet is removed and the needle is attached to a 
connecting tube (Mini-Volume Line; Insung Medical, Seoul, 
Korea) and is flushed with Lipiodol (Fig. 3). The needle tip 
is positioned in the transitional zone between the cortex 
and the hilum of the lymph node (Fig. 3). 
Lipiodol injection is observed under fluoroscopic guidance 
to identify the efferent lymphatic or lymph node so as 
to confirm the proper positioning of the needle. A total 
volume of 10–20 mL of Lipiodol is injected using the 
dedicated lymphangiogram pump or, more commonly, an 
advanced anesthesia injection pump is used at the injection 
rate of 0.2–0.4 mL/minute. Upward serial fluoroscopic spot 
images are obtained every 5–10 minutes over the course of 
Lipiodol injection.
Intranodal LG is considered to be technically successful 
if the target lymph node is successfully selected and the 
lymphatic channels of interest including cisterna chyli are 
adequately visualized using Lipiodol.
Follow-Up CT Scans after LG
For a diagnostic purposes, follow-up non-contrast 
computed tomography (CT) scans are obtained to delineate 
the lymphatic vessels, assess the site of leakage, and 




Fig. 2. 35-year-old man with left chylothorax after lung biopsy using video-assisted thoracoscopy.
A. Axial CT scan obtained one week prior to LG shows large amount of left pleural effusion (chylothorax). B. Isolated lymphatic of dorsum of right 
foot was cannulated using 30-G LG needle and both needle and lymphatic were firmly tied (arrow). C. Radiographic image obtained 5 minutes 
following Lipiodol injection shows Lipiodol extravasation (arrows) at calf level. D, E. Radiographic images obtained 15 minutes following Lipiodol 
injection show good opacification of inguinal and pelvic lymph nodes as well as ascending lymphatics. LG = lymphangiography
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sclerotherapy.
Those follow-up CT scans are obtained immediately 
after injecting the full volume of Lipiodol in patients with 
inguinal or pelvic leakage, or 4–5 hours after the injection 
in patients with abdominal or thoracic leakage (Fig. 2) (1, 
4). 
Thoracic Duct Embolization
Once the retroperitoneal lymphatics along the upper 
lumbar region and cisterna chyli are opacified with Lipiodol, 
percutaneous cannulation of cisterna chyli is performed 
using 22-G Chiba needle (15 or 20 cm) (Fig. 3). Under the 
fluoroscopic guidance, the needle is entered at slightly 
right paramedian location in the supra-umbilicus region. 
Transabdominally, the needle traverses the abdomen to 
access the cisterna chyli. The needle should be slightly 
angled cranially to provide a less acute angle entering the 
cisterna chyli with a wire. During this process, a lateral 
projection angiography is useful to more accurately identify 
and access the cisterna chyli. 
Once the cisterna chyli or large lymphatic duct is accessed 
with a needle, a 0.018 or 0.014 inch microwire is used to 
thread the thoracic duct. Once the microwire is in a secure 
location in the thoracic duct, a microcatheter (Renegade STC 
18; Boston Scientific, Cork, Ireland) is advanced over the 
microwire in the thoracic duct. A small amount of contrast 
is injected to confirm the proper entry to the thoracic 
duct and also to verify the extravasation and leak. Once 
the leak is identified, the microwire and microcatheter are 
advanced past the leak and microcoils are used to embolize 
the thoracic duct. Usually, 2–4 mm long detachable fibered 
coils, either the Interlock coil (Boston Scientific, Cork, 
Ireland) or Concerto coil (Covidien, Plymouth, MN, USA), 
are used to shorten the procedure time. A shorter pushable 
coil (Tornado or MicroNester coils; Cook, Bloomington, IN, 
USA) can also be used. The proximal and distal thoracic duct 
around the leak is embolized with coils and the proximal 
thoracic duct is usually further embolized with N-butyl-2-
cyanoacrylate or Onyx glue (Covidien, Plymouth, MN, USA) 
to completely occlude the thoracic duct.
Due to the size of the thoracic duct or cisterna chyli 
or the anatomic variants of thoracic duct, thoracic duct 
cannulation may not be possible. In those cases, instead of 
TDE, thoracic duct obliteration or cisterna chyli obliteration 
can be performed (10). Instead of accessing the cisterna 
chyli with a microwire and microcatheter, the proximal 
thoracic duct or cisterna chyli within the abdomen can be 
perforated with needle. This prevents chylous lymphatics 
from travelling up to the distal thoracic duct which may 
have leaks. Lymphatics leaking at the site of obliteration 
may cause chylous ascites that could be re-absorbed by the 
abdominal visceral organs.
F G H
Fig. 2. 35-year-old man with left chylothorax after lung biopsy using video-assisted thoracoscopy.
F, G. Radiographic anteroposterior and lateral images obtained one hour following Lipiodol injection show pseudoaneurysm-like leakage 
(arrows) of Lipiodol at 9th thoracic spine level. H. CT reconstructed image obtained 5 hours following LG shows leakage site (arrow) adjacent to 
descending thoracic aorta and prominent Lipiodol leakage to left lung. Left chest tube draining 700 mL per day was eliminated three days after 
LG. LG = lymphangiography
Korean J Radiol 15(6), Nov/Dec 2014 kjronline.org728
Lee et al.
Clinical Applications
Chylothorax and Chylous Ascites
Chylothorax is a rare but devastating complication 
associated with mediastinal lymph node or lymphatic injury 
within highly variable course of the thoracic duct (16). 
Similarly, any source of lymphatic obstruction or leakage 
can cause lymphatic accumulations in the peritoneal 
A
C D E F G
B
Fig. 3. 65-year-old man with history of esophageal cancer; status post total esophagectomy who presented with average of 2–3 L 
of left chylous effusion.
A. 25-G spinal needle (arrowheads) is assembled to connecting tube (arrows) and is flushed with Lipiodol contained in syringe tube. B. 
Ultrasound-guided inguinal lymph node (arrows) access for initiation of intranodal LG using 25-G spinal needle (arrowheads). C. Initial spot 
image of right pelvis/inguinal region demonstrating needle (arrow) access of small lymph node and opacification of proximal lymphatic vessels 
and lymph node. D. Follow-up spot image of lower abdomen demonstrating upward move/flow of lymphatics (arrows) and appearance of cisterna 
chyli (arrowhead). E. Subsequent follow-up spot image of thoracolumbar region demonstrating continued upward flow of lymphatics with filling 
of cisterna chyli (arrowhead) and evidence of lymphatic leak showing in upper thoracic region with pooling of Lipiodol contrast (arrow). F. 
Cisterna chyli is percutaneously accessed using 22-G Chiba needle (arrow) and once it is accessed, microwire (arrowheads) is used to secure 
access by advancing it to mid thoracic duct. G. In this patient, microwire and microcatheter were unable to advance beyond leak along thoracic 
duct. Decision was made to coil embolize thoracic duct proximal to leak using several detachable coils (arrows) and it was further embolized 
using NBCA (arrowhead) down to cisterna chyli. On post-TDE day 1, chylous effusion completely stopped and chest tube drainage decreased to 
less than 50 mL from 3 L. LG = lymphangiography, NBCA = N-butyl-2-cyanoacrylate, TDE = thoracic duct embolization
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or retroperitoneal cavities, resulting in chylous ascites. 
Conservative management is recommended as the best 
initial treatment and includes drainage tube insertion, 
medium chain triglyceride diet and sometimes total 
parenteral nutrition. Chylothorax and chylous ascites with 
persistent high output may be treated with intravenous 
somatostatin analogues such as octreotide or pleurodesis 
(7). 
If conservative management fails, surgical management, 
such as pleura- or peritoneovenous shunt implantation, 
lymphatic-venous anastomoses, and ligation or clipping 
of the lymphatics, is undertaken (4). General indications 
for surgery for postoperative chylothorax and chylous 
ascites include chylous leak greater than 1000 mL/day for 
more than 5 days, persistent leak for more than 2 weeks 
despite conservative management, or development of 
insurmountable nutritional or metabolic complications (4). 
Lymphangiography has been used mainly to identify the 
site of the lymphatic leakage in patients with chylothorax 
and chylous ascites (Fig. 2). Based on three studies, the 
leakage sites were successfully identified between 64% to 
86% of patients with chylothorax and chylous ascites and 
LG achieved successful therapeutic outcome in 56% to 86% 
of cases (3, 4, 7).
Percutaneous catheterization and embolization of 
the thoracic duct has been employed in patients with 
A
B C D
Fig. 4. 45-year-old man with right inguinal area swelling after deep inguinal lymph node dissection.
A. Axial CT scan shows lymphocele (asterisk), which was subsequently dissected, in right inguinal area. Note minimal fluid collection at left 
superficial inguinal lymph node dissection site. B. Radiographic image obtained 30 minutes following Lipiodol injected into lymphatics of dorsum 
of foot, shows disruption of lymphatic with Lipiodol leakage (arrow) at entrance of open wound in right inguinal area. C. Radiographic image 
obtained 14 hours following Lipiodol injection, still shows leakage point (arrow). D. CT scan obtained 20 hours following Lipiodol injection shows 
disrupted lymphatic (arrow). Leakage was eliminated five days following LG. LG = lymphangiography
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postoperative chylothoraces (Fig. 3). The procedure is 
technically challenging and catheterization of the thoracic 
duct is only successful in approximately 67% (12). When 
the thoracic duct is successfully catheterized and embolized, 
the success rate for resolution of chylothorax is 90% (12). 
Experience with this technique is limited and trials that 
compare this technique to thoracic duct ligation have not 
been performed. 
Lymphatic Fistula
Lymphatic fistula occurs most commonly after 
lymphadenectomy (3, 7). Operations of aortic aneurysm 
or bypass can be the causes of lymphatic fistula (3, 7). 
Lymphatic fistula is connected with the surrounding organs 
including the urinary tract, gastrointestinal tract, or uterine 
cervix/vagina, or it can be opened to surrounding free 
tissue, causing lymphatic accumulation (Fig. 4) (7, 9, 17). 
When a lymphatic fistula is located superficially, external 
compression may be applied (7). When conservative 
treatment or external compression fails, LG can offer 
diagnosis as well as therapy (Fig. 4). In lymphatic fistula, 
LG enables successful visualization of the leakage and 
therapeutic outcome in 75% of cases, which is comparable 
to the success rates in chylothorax and chylous ascites (7). 
Lymphocele
Most postoperative lymphoceles are small and resolve 
without treatment. However, in 4–7% of patients with 
postoperative lymphoceles, lymphoceles persist resulting 
in pain, infection, or compression of vital structures, which 
A
B C D
Fig. 5. 59-year-old man with history of nephroureterectomy and pelvic lymph node dissection.
A. Axial CT scan shows large retroperitoneal lymphocele (asterisk) displacing both bowel and right kidney. B. Radiographic image obtained 20 
minutes following Lipiodol injection into left inguinal lymph node shows good opacification of lymphatics in left pelvic cavity. C, D. Radiographic 
images obtained four and 16 hours following Lipiodol injection shows Lipiodol leakage (arrows) at 4th lumbar spine level and scattered Lipiodols 
(arrowheads) within lymphocele cavity as well as drainage tube. 
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require an intervention (18, 19). Lymphoceles seem to be 
difficult to treat with LG despite direct visualization of 
Lipiodol leakage during LG (Fig. 5) (7). 
In patients with lymphocele, the therapeutic success of 
LG seems discouraging. Kos et al. (7) reported that there 
was no therapeutic success with pedal LG in three patients 
with lymphocele. As a lymphocele is a lymph-filled space 
without a distinct epithelial lining, Lipiodol seems to be 
passed into the open space without inducing inflammatory 
or granulomatous reaction at the leakage site. In cases of 
superficial lymphocele, external compression may be applied 
(7). Local sclerotherapy has shown a high success rate of 
77–94% in patients with postoperative lymphocele (18, 20, 
21) and so is preferable to LG in patients with lymphocele. 
Complications
Since pedal and intranodal LG procedures are invasive 
procedures including incision or puncture, there are inherent 
risks such as infection, pain, and Lipiodol extravasation 
during injection (Fig. 2) (9, 12). 
Serious complications have also been reported including 
intra-alveolar hemorrhage, Lipiodol emboli in the pulmonary 
vasculature, allergic reactions to Lipiodol, and extravasation 
of Lipiodol into the soft tissue (2, 22-24). Contraindications 
for LG include pulmonary insufficiency or right-to-left 
cardiac shunt; the former increases the potential risk of 
exacerbation by pulmonary embolism through Lipiodol, and 
the latter creates a risk of cerebral embolism (25).
As complications are frequently related to the volume of 
Lipiodol injected, the overall complications associated with 
LG are low when the volume injected is less than 10 mL for 
the extremity (2).
As for TDE, due to its current approach of percutaneous 
transabdominal access of cisterna chyli/thoracic duct, 
inevitable punctures of different organs including bowels, 
liver, pancreas, inferior vena cava, and aorta may occur. 
However, only a 22-G Chiba needle is being used and no 
clinically significant complications have been experienced 
by the authors or been reported (12, 13). Two types of 
major complications can occur Glue pulmonary embolism 
results when excess glue escapes through the thoracic duct 
into the subclavian vein and causes symptomatic pulmonary 
embolism. Peripheral lower extremity edema can result due 
to disruption of peripheral lymphatics with pedal LG; this is 
no longer an issue with nodal LG.
Summary
Lymphangiography in conjunction with thoracic duct 
embolization is a relatively safe, powerful, and reliable 
interventional method. It enables identification of 
lymphatic leakage and provides complete occlusion, 
which results in complete resolution of one of the most 
devastating complications of thoraco-abdominal surgery.
Due to its minimally invasive nature and its proven 
effectiveness, the need for reoperation and exposure to 
perioperative morbidity may be avoided.
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